17
Views
0
CrossRef citations to date
0
Altmetric
Articles

Effects of atypical pneumonia agents on progression of atherosclerosis and acute coronary syndrome

, , , , , , & show all
Pages 593-598 | Received 06 Apr 2007, Accepted 29 Aug 2007, Published online: 23 May 2017

References

  • Kaplan M, Yavuz SS, Cinar B, Koksal V, Kut MS, Yapici F, Gercekoglu H, Demirtas MM. Detection of Chlamydia pneu-moniae and Helicobacter pylori in atherosclerotic plaques of carotid artery by polymerase chain reaction. Int J Infect Dis 2006; 10: 116–23.
  • Monaco C, Rossi E, Milazzo D, Citterio F, Ginnetti F, D’Onofrio G, Cianflone D, Crea F, Biasucci LM, Maseri A. Persistent systemic inflammation in unstable angina is largely unrelated to the atherothrombotic burden. J Am Coll Car-diol 2005; 45: 238–43.
  • Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, Huttunen JK, Valtonen V. Serological evi-dence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarc-tion. Lancet 1988; 2: 983–6.
  • Thom DH, Grayston JT, Siscovick DS, Wang SP, Weiss NS, Daling JR. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992; 268: 68–72.
  • Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm AJ, Northfield TC. Relation of Heli-cobacter pylori infection and coronary heart disease. Br Heart J1994; 71: 437-9.
  • Strachan DP, Mendall MA, Carrington D, Butland BK, Yarnell JW, Sweetnam PM, Elwood PC. Relation of Helicobacter pylori infection to 13 year mortality and inci-dent ischemic heart disease in the Caerphilly Prospective Heart Disease Study. Circulation 1998; 98: 1286–90.
  • Zhou YF, Leon MB, Waclawiw MA, Popma JJ, Yu ZX, Finkel T, Epstein SE. Association between prior cytomegalovirus infection and the risk of restenosis after coro-nary atherectomy. N Eng J Med 1996; 335: 624–30.
  • Mitusch R, Luedemann J, Wood WG, Berger K, Schminke U, Suter M, Kessler C, John U, Rupp J, Kentsch M, Maass M. Asymptomatic carotid atherosclerosis is associated with circulating chlamydia pneumoniae DNA in younger nor-motensive subjects in a general population survey. Ante-rioscler Thromb Vasc Biol 2005; 25: 386–91.
  • Blasi F, Boman J, Esposito G, Melissano G, Chiesa R, Cosentini R, Tarsia P, Tshomba Y, Betti M, Alessi M, Morelli N, Alleqra L. Chlamydia pneumoniae DNA detection in peripheral blood mononuclear cells is predictive of vas-cular infection. J Infect Dis 1999; 180: 2074–6.
  • Wong YK, Dawkins KD, Ward ME. Circulating Chlamydia pneumoniae DNA as a predictor of coronary artery disease. J Am Coll Cardiol 1999; 34: 1435–9.
  • Dore MP, Sepulveda AR, Bacciu PP, Blasi F, Simula L, Marras L, Piccolo D, Cherchi GB, Graham DY, Realdi G. Detection of Chlamydia pneumoniae but not Helicobacter pylori DNA in atherosclerosis plaques. Dig Dis Sci 2003; 48: 945–51.
  • Rassu M, Cazzavillan S, Scagnelli M, Peron A, Bevilacqua PA, Facco M, Bertoloni G, Lauro FM, Zambello R, Bonoldi E. Demonstration of Chlamydia pneumoniae in atheroscle-rotic arteries from various vascular regions. Atherosclerosis 2001; 158: 73–9.
  • Chiu B, Viira E, Tucker W, Fong IW Chlamydia pneumoniae, Cytomegalovirus, and Herpes Simplex Virus in atherosclero-sis of the carotid artery. Circulation 1997; 96: 2144–8.
  • Tong CYW, Sillis M. Detection of Chlamydia pneumoniae and Chlamydia psittaci in sputum sample by PCR. J Clin Pathol 1993; 46: 313–7.
  • Song H, Tasaki H, Yashiro A, Yamashita K, Taniguchi H, Nakashima Y Acute-phase proteins and Chlamydia pneu-moniae infection which one is more important in acute coro-nary syndrome? Jpn Circ J2001; 65: 853–7.
  • Curzen N, Fox K. Inflammation and outcome in unstable angina. Eur Heart J 1999; 20: 554–5.
  • Roivainen M, Viik-Kajander M, Palosuo T, Toivanen P, Leinonen M, Saikku P, Tenkanen L, Manninen V, Hovi T, Manttari M. Infections, inflammation and the risk coronary heart disease. Circulation 2000; 101: 252–7.
  • Hoymans VY, Bosmans JM, Ursi D, Martinet W, Wuyts FL, Van Marck E, Altwegg M, Vrints CJ, Ieven MM. Immuno-histostaining assays for detection of Chlamydia pneumoniae in atherosclerotic arteries indicate cross-rections with nonch-lamydial plaque constituents. J Clin Microbiol 2004; 42: 3219–24.
  • Porqueddu M, Spirito R, Parolari A, Zanobini M, Pompilio G, Polvani G, Alamanni F, Stangalini D, Tremoli E, Biglioli P. Lack of association between serum immunore-activity and Chlamydia pneumoniae detection in the human aortic wall. Circulation 2002; 106: 2647–8.
  • Dowell SF, Peeling RW, Boman J, Carlone GM, Fields BS, Guarner J, Hammerschalaq MR, Jackson LA, Kuo CC, Maass M, Messmer TO, Talkington DF, Tondella ML, Zaki SR; Chlamydia pneumoniae workshop participants. Stan-dardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 2001; 33: 492–503.
  • Romano S, Penco M, Fratini S, Di Pietro M, Sessa R, Del Piano M, Fedele F, Dagianti A. Chlamydia pneumoniae infection is associated with coronary artery disease but not implicated in inducing plaque instability. Int J Cardiol 2004; 95: 95–9.
  • Adiloglu AK, Can R, Nazli C, Ocal A, Ergene 0, Tinaz G, Kisioglu N. Ectasia and severe atherosclerosis; Relationships with Chlamydia pneumoniae, Helicobacter pylori, and inflam-matory markers. Tex Heart Inst J2005; 32: 21-7.
  • Hoymans V, Bosmans J, Ursi D, Dubois F, Van Marck E, Altwegg M, Ieven M, Vrints C. Systemic inflammation, Chlamydia pneumoniae DNA in circulating leukocytes and coronary atherosclerosis. Acta Cardiol 2002; 57: 213–9.
  • Rassu M, Ca77avillan S, Scagnelli M, Peron A, Bevilacqua PA, Facco M, Bertoloni G, Lauro FM, Zambello R, Bonoldi E. Demonstration of Chlamydia pneumoniae in athemsclerotic arteries from vascular regions. Atherosclerosis 2001; 158: 73–9.
  • Gaydos CA, Summergill JT, Sahney NN, Ramirez JA, Quinn TC. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun 1996; 64: 1614–20.
  • Ross R. Atherosclerosis. An inflammatory disease. N Engl J Med 1999; 340: 115–26.
  • Bloemenkamp DGM, Mali WPM, Tanis BC, Rosendaal FR, van den Bosch MA, Kemmeren JM, Algra A, Ossewaarde JM, Visseren FLJ, van Loon AM, van der Graaf Y. Chlamy-dia pneumoniae, Helicobacter pylori and Cytomegalovirus infections and the risk of peripheral arterial disease in young women. Atherosclerosis 2002; 163: 149–56.
  • Zuni A, Hare DL, Horrigan M, Buxton BF. The resistance of the IMA to atherosclerosis might be associated with its higher eNOS, ACE and ET-A receptor immunoreactivity. Arterioscler Thromb Vasc Biol 2003; 23: 1308.
  • Tector AJ, Schmahl TM, Janson B, Kallies JR, Johnson G. The internal mammary artery graft: its longevity after coronary bypass. JAMA 1981; 246: 2181–3.
  • Luscher TF, Diederich D, Siebenmann R, Lehmann K, Stulz P, von Segesser L, Yang ZH, Turina M, Gradel E, Weber E, et al. Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med 1988; 319: 462–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.